Dr Norman Swan has called for more robust surgical and N95 masks to replace the common cloth versions for everyday use by Australians.
The ABC presenter said the familiar blue paper masks and simple cloth versions are not up to the task of preventing the spread of the more contagious Omicron strain and Australians need to upgrade to more heavy-duty protection.
‘As the virus becomes more infectious there’s less tolerance for aerosol escaping through the mask,’ he told the ABC.
Nanosynth Group plc (LON:NNN) is focused on the synthesis and application of nanoparticles. The group uses a patented process developed by Dr Cave at Nottingham Trent University. It has three subsidiaries; Pharm 2 Farm Ltd, nanosynth ltd and Cloudveil.